Burning Rock Biotech Limited
BNR
$16.76
-$0.07-0.42%
NASDAQ
| 12/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.10% | -2.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.10% | -2.51% | |||
| Cost of Revenue | -14.51% | -1.02% | |||
| Gross Profit | 0.68% | -3.11% | |||
| SG&A Expenses | 4.03% | 2.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.45% | 2.84% | |||
| Operating Income | 24.65% | -20.69% | |||
| Income Before Tax | 11.46% | -112.73% | |||
| Income Tax Expenses | 317.57% | 2,528.83% | |||
| Earnings from Continuing Operations | 7.30% | -126.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.30% | -126.33% | |||
| EBIT | 24.65% | -20.69% | |||
| EBITDA | -103.86% | -490.07% | |||
| EPS Basic | 4.65% | -126.05% | |||
| Normalized Basic EPS | 8.95% | -14.24% | |||
| EPS Diluted | 4.65% | -126.05% | |||
| Normalized Diluted EPS | 8.95% | -14.24% | |||
| Average Basic Shares Outstanding | -2.76% | 0.13% | |||
| Average Diluted Shares Outstanding | -2.77% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||